This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by McCartan, D. Articles by King, D. J. Search for Related Content PubMed PubMed Citation Articles by McCartan, D. Articles by King, D. J. Social Bookmarking                         What's this?

The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers

The Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Belfast

Robert Bell

School of Psychology, The Queen's University of Belfast, Belfast

Jonathan F. Green

Clarke Campbell

Karen Trimble

The Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Belfast

Alan Pickering

Department of Psychology, St George's Hospital Medical School, London, UK

David J. King

The Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland; d.king{at}qub.ac.uk

Latent inhibition (LI) is a measure of reduced learning about a stimulus to which there has been prior exposure without any consequence. It therefore requires a comparison between a pre-exposed (PE) and a non-pre-exposed (NPE) condition. Since, in animals, LI is disrupted by amphetamines and enhanced by antipsychotics, LI disruption has been proposed as a measure of the characteristic attentional deficit in schizophrenia: the inability to ignore irrelevant stimuli. The findings in humans are, however, inconsistent. In particular, a recent investigation suggested that since haloperidol disrupted LI in healthy volunteers, and LI was normal in non-medicated patients with schizophrenia, the previous findings in schizophrenic patients were entirely due to the negative effects of their medication on LI (Williams et al., 1998). We conducted two studies of antipsychotic drug effects on auditory LI using a within-subject, parallel group design in healthy volunteers. In the first of these, single doses of haloperidol (1 mg. i.v.) were compared with paroxetine (20 mg p.o.) and placebo, and in the second, chlorpromazine (100 mg p.o.) was compared with lorazepam (2 mg. p.o.) and placebo. Eye movements, neuropsychological test performance (spatial working memory (SWM), Tower of London and intra/extra dimensional shift, from the CANTAB test battery) and visual analogue rating scales, were also included as other measures of attention and frontal lobe function. Haloperidol was associated with a non-significant reduction in LI scores, and dysphoria/akathisia (Barnes Akathisia Rating Scale) in three-quarters of the subjects. The LI finding may be explained by increased distractibility which was indicated by an increase in antisaccade directional errors in this group. In contrast, LI was significantly increased by chlorpromazine but not by an equally sedative dose of lorazepam (both drugs causing marked decreases in peak saccadic velocity). Paroxetine had no effect on LI, eye movements or CANTAB neuropsychological test performance. Haloperidol was associated with impaired SWM, which correlated with the degree of dysphoria/akathisia, but no other drug effects on CANTAB measures were detected. We conclude that the effect of antipsychotics on LI is both modality and pharmacologically dependent and that further research using a wider range of antipsychotic compounds is necessary to clarify the cognitive effects of these drugs, and to determine whether there are important differences between them.

Key Words: antipsychotics • cognition • healthy volunteers • latent inhibition • schizophrenia

Journal of Psychopharmacology, Vol. 15, No. 2, 96-104 (2001)
DOI: 10.1177/026988110101500211


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R E Lubow Construct Validity of the Animal Latent Inhibition Model of Selective Attention Deficits in Schizophrenia Schizophr Bull, January 1, 2005; 31(1): 139 - 153. [Abstract] [Full Text] [PDF]

				S. L. Barrett, R. Bell, D. Watson, and D. J. King Effects of Amisulpride, Risperidone and Chlorpromazine on Auditory and Visual Latent Inhibition, Prepulse Inhibition, Executive Function and Eye Movements in Healthy Volunteers J Psychopharmacol, June 1, 2004; 18(2): 156 - 172. [Abstract] [PDF]

				S. Kapur Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia Am J Psychiatry, January 1, 2003; 160(1): 13 - 23. [Abstract] [Full Text] [PDF]